Related Experiment Video
Updated: Jul 28, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Prostate cancer screening in a Saudi population: an explanatory trial study
Prostate Cancer and Prostatic Diseases
|January 13, 2010
Summary
Prostate cancer screening in Saudi Arabia found a 2.5% prevalence in healthy men. Early detection is crucial as many diagnosed cases were advanced, highlighting the need for further research.
Area of Science:
- Urology
- Oncology
- Public Health
Background:
- Prostate cancer is a significant health concern globally.
- Screening criteria exist but their feasibility in diverse populations requires evaluation.
- Understanding the prevalence in Saudi Arabia is essential for targeted health strategies.
Purpose of the Study:
- To assess the prevalence of prostate cancer in a healthy Saudi Arabian male cohort.
- To evaluate the feasibility of international screening criteria in this population.
- To identify key demographic and clinical factors associated with prostate cancer detection.
Main Methods:
- A screening study involving 2100 healthy males in Riyadh.
- Utilized Prostate-Specific Antigen (PSA) blood testing and Digital Rectal Examination (DRE).
- Diagnostic confirmation via transrectal ultrasound and prostatic biopsies for abnormal results.
Main Results:
- A total of 2.5% (52/2100) of participants were diagnosed with prostate cancer.
- Elevated PSA levels were more common in older age groups (61-70 years).
- A significant proportion of detected cancers were advanced (metastatic in 26.9%).
Conclusions:
- Prostate cancer screening in Saudi Arabia revealed a higher-than-expected prevalence.
- The advanced stage at diagnosis suggests potential limitations in current screening approaches.
- Further large-scale, community-based studies are recommended, particularly for high-risk groups.
